Oct. 22 at 7:35 PM
Applied DNA Sciences, Inc. (NASDAQ:
$BNBX) announced the successful close of its up to
$58 million private placement financing and the official launch of its yield-focused BNB digital asset treasury strategy, with initial BNB holdings valued at over
$17 million.
Applied DNA Sciences is a B2i Digital Featured Company. A full company profile will be available soon at https://b2idigital.com/featured-companies.
Today’s financing brings
$27 million in gross proceeds (
$15.3M in cash/stablecoins,
$11.7M in
$OBNB trust units) with potential for an additional
$31 million from warrant exercises. The company has also streamlined operations, achieving approximately
$2.9 million in annualized cost savings while pivoting toward digital asset opportunities.
The financing structure details include:
• Initial BNB holdings totaling 15,555 tokens valued at over
$17 million (10,647 via
$OBNB trust units, 4,908 purchased directly)
•
$27 million raised through PIPE financing with up to
$31 million additional from future warrant exercises
• Operational restructuring delivering
$2.9 million in annualized cost savings
• Launch of yield-focused BNB treasury strategy positioning
$BNBX as institutional-grade access to Binance ecosystem
CEO Clay Shorrock, noted “In addition to launching our digital asset treasury, we believe we have taken decisive steps to streamline our cost structure and position the Company for long-term sustainability. By aligning resources with strategic priorities, we believe we are well positioned to execute with discipline, deliver durable value to shareholders, and advance our differentiated mission.”
See the full news release at: https://s3.amazonaws.com/b2icontent.irpass.cc/2592/rl158713.pdf
Applied DNA is led by Clay Shorrock, Chief Executive Officer and President; and Beth Jantzen, Chief Financial Officer. The company’s advisory team includes Anthony Scaramucci, Founder and Managing Partner of SkyBridge Capital, as Strategic Capital Markets Advisor; Patrick Horsman (CFA), as Chief Investment Officer (pending appointment); Josh Kruger, as Chairman of the Board (nominated); and JR Pasch, as Strategic Advisor.
To learn more about Applied DNA Sciences, Inc., visit https://investors.adnas.com. For investor inquiries, contact
[email protected].
Discover more emerging growth Featured Companies, industry-leading Featured Experts, and upcoming Featured Conferences at https://b2idigital.com.